Corrigendum: Combination therapy with fingolimod and neural stem cells promotes functional myelination in vivo through a non-immunomodulatory mechanism

In the original article by Zhang Y. et al., entitled “Combination Therapy With Fingolimod and Neural Stem Cells Promotes Functional Myelination in vivo Through a Non-immunomodulatory Mechanism” (Front Cell Neurosci. 2019 Feb 5;13:14. doi: 10.3389/fncel.2019.00014. eCollection 2019; PMID: 30804753), due to a mistake made during figure preparation, there is an error in the CC1-GFP-stained image in the PBS and FTY720 group of Figure 2B. The correct Figure 2 is displayed below, and its legend remains the same. The authors confirm that all of the results and conclusions of the article remain unchanged. The authors sincerely apologize for this mistake.